Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid plus oxytocin versus oxytocin alone for bleeding reduction after cesarean section
IRCT20230307057644N2Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Control: oxytocin alone with Intervention: tranexamic acid + oxytocin (2 arms). Primary endpoint: Amount of bleeding. Started May 2023; status: completed.
02
Drugs
tranexamic acidoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT20230307057644N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230307057644N2.